Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease

OBJECTIVE: To evaluate the cost-effectiveness of enzyme replacement therapy (ERT) compared to standard medical care without ERT in the Dutch cohort of patients with type 1 Gaucher disease (GD I). DESIGN: Cost-effectiveness analysis was performed using a life-time state-transition model of the diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dussen, Laura, Biegstraaten, Marieke, Hollak, Carla EM, Dijkgraaf, Marcel GW
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022049/
https://www.ncbi.nlm.nih.gov/pubmed/24731506
http://dx.doi.org/10.1186/1750-1172-9-51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022049/
https://www.ncbi.nlm.nih.gov/pubmed/24731506
http://dx.doi.org/10.1186/1750-1172-9-51

Ejemplares similares